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Received 25 February 2010; received in revised form 20 August 2010; accepted 20 August 2010Abstract Periventricular white matter injury (PVWMI) in preterm infants is a leading cause of cerebral palsy.
Mesenchymal stem cell (MSC) transplantation in experimental models of adult demyelinating conditions is reported to
reduce neurological deficits so we investigated their potential for treating developmental PVWMI. Neonatal rat MSCs, when
cultured and labeled in vitro with fluorescent, micrometer-sized paramagnetic iron oxide particles (MPIO), retained their
differentiation potential. Rats received bilateral intracerebral injections of ibotenic acid at postnatal day 5 causing
PVWMI-like lesions with localized hypomyelination and sensorimotor deficits. MPIO-labeled MSCs were transplanted near
the lesion in the right hemisphere 1 day postlesioning. Animals receiving cell transplants showed significantly increased
antimyelin immunoreactivity in the corpus callosum, and improved reaching and retrieval skills, compared to animals
receiving conditioned medium only. In separate experiments, in vivo MRI demonstrated that MPIO-labeled cells migrated
away from the injection site toward lesioned areas in both hemispheres, confirmed by microscopy postmortem, but
double-labeling studies found little evidence of differentiation into neural phenotypes. MSC transplantation led to
significantly more forebrain cell proliferation, assayed by bromodeoxyuridine incorporation, than in controls. MSC
transplants may have been neuroprotective and indirectly contributed to brain repair.
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256 A. Chen et al.IntroductionBrain lesions in the premature infant are relatively common
and, with major advances in intensive care, nearly 90% of
such infants survive. However 10% subsequently have
cerebral palsy and an additional 25–50% later manifest
cognitive and/or behavioral deficits (Hack et al., 2005;
Volpe, 2001). Periventricular white matter injury (PVWMI)
the most frequent form of such lesions is caused by localized
ischemia arising from developmental immaturity of the
cerebral blood supply (Marin-Padilla, 1997). Multifocal
lesions deep in the subcortical white matter disrupt nerve
fiber pathways leaving cortical neurons intact. Corticospinal
axons subsequently regrow to, but fail to cross, the damaged
area and instead make abnormal intracortical connections
(McQuillen and Ferriero, 2004). Although there have been
extensive investigations to elucidate the mechanisms lead-
ing to PVWMI (Volpe, 2009; Leviton and Gressens, 2007)
which have led to testing of anti-inflammatory and anti-
excitotoxic treatments in animal models (Wolfberg et al.,
2007; Manning et al., 2008; Gressens et al., 2008) as yet
clinically applicable treatments are not forthcoming. Inter-
ventions which could repair the localized damage might
induce nerve fibers to regrow through periventricular areas
and ultimately to find their appropriate targets. Glial scars
that inhibit axon growth are not formed initially in PVWMI
(Marin-Padilla, 1997; Leviton and Gressens, 2007) and fibers
at this developmental stage will be in “growing mode,”
encountering the normal developmental signals that enable
target finding and establishment of appropriate synapses
(Terashima, 1995; Maier and Schwab, 2006).
Research suggests that stem cells from various sources
can promote repair of the central nervous system (CNS)
(Keirstead et al., 1999, 2005; Bachelin et al., 2005; Lima et
al., 2006; Windrem et al., 2004; Zhang et al., 1999) including
mesenchymal stem cells (MSCs) derived from bone marrow or
umbilical cord blood, that are possibly able to acquire neural
characteristics in vitro or after transplantation (Azizi et al.,
1998; Mezey et al., 2003; Stewart and Przyborski, 2002;
Wislet-Gendebien et al., 2005; Deng et al., 2006). However,
it seems more likely that they act through supporting
neuronal survival or regeneration, with only a limited
capacity for transdifferentiation into astrocytes only
(Zwart et al., 2008, 2009; Rooney et al., 2009). Therefore,
with banking of cord blood from premature babies and
advances in radiological scanning now permitting early
identification of brain lesions and confident prediction of
likely levels of future disability (Davatzikos et al., 2003;
Hoon et al., 2009; Mathur and Inder, 2009; Ment et al., 2009)
early autotransplantation of cord blood-derived stem cells
could provide a novel approach to repairing PVWM lesions.
We previously developed a rat model of PVWMI involving
bilateral injection of ibotenic acid (IBA) into subcortical
white matter at postnatal day (P) 5 (Chen et al., 2008). This
caused measurable deficits in myelination of the corpus
callosum (CC) beneath the sensorimotor cortex modeling
white matter injury in humans (Back et al., 2001), enlarged
ventricles modeling grey matter reduction (Inder et al.,
2004), and behavioral deficits in corticospinal-dependent
motor control. The present study assessed the potential for
allogenic MSC transplantation to restore myelination, ven-tricle size, and skilled motor control in our animal model. A
short interval between lesion and transplantation was chosen
because disconnection of corticospinal projections during
development results in aberrant neural circuit formation
(Clowry, 2007) and so the aim is to rescue this pathway as
quickly as possible. However, the disadvantage to this is that
the inflammatory effects of inducing PVWMI are not resolved
at the time of injection. In addition, the possibilities for
tracking progress of transplanted MSCs both in vivo with
magnetic resonance imaging (MRI) and postmortem by
fluorescence microscopy by prelabeling them with fluores-
cent micrometer-sized paramagnetic iron oxide particles
(MPIO) in culture were explored.
Results
Characterization of MSCs and MPIO-labeled MSCs
Rat MSCs from neonatal bone marrow were isolated by their
adherence to a plastic tissue culture surface. As shown in
Fig. 1, the rat MSCs have two distinct populations, large
flattened cells and relatively elongated or spindle-shaped
cells, similar to published descriptions of rat and human MSCs
(Woodbury et al., 2002). Immunofluorescent staining (not
shown) and flow cytometric analysis (Fig. 1A) demonstrated
that greater than 90% of these cells coexpressed the
mesenchymal stem cell markers CD54, collagen type 1, and
integrin β1 (although they failed to express detectable
fibronectin), but not the hematopoietic stem cell (HSC)
markers CD45 and CD14. MSCs maintained their osteogenic
and adipogenic potential after long-term culture in vitro.
The optimum concentration of MPIO particles was found
to be 10 μl/ml of medium. Twenty hours of incubation with
MPIO particles at this concentration labeled more than 85%
of cells, which was maintained for at least 4–5 passages.
Higher concentrations did not increase the labeling effi-
ciency (Fig. 1B). No obvious toxic effects were found in
culture with any tested concentration. MPIO particles were
seen in cytoplasm by fluorescence microscopy (Fig. 1C).
Following incubation with MPIO particles, MSCs grew
normally, and kept their adipogenic and osteopogenic
potential even after 10 passages (Figs. 1D–G). These
observations suggest that the MSCs used in subsequent
experiments were a phenotypically homogenous cell pop-
ulation, and MPIO labeling did not change their cellular
biology and differentiation potential.
Survival, distribution, and differentiation of the
grafted MSCs
In vivo MRI scanning indicated that MPIO-labeled cells
migrated ventrally and laterally in the brain after grafting.
As shown in Figs. 2A–D MPIO labeling, identified by a
hypointense signal, was found in the contralateral CC in 2
out of 4 animals from 8 to 49 days posttransplantation,
whereas in 3 from 4 animals label moved along the fornix and
the fimbria of hippocampus toward posterior locations in the
forebrain (Fig. 2E). No migration was observed following
injection of cells into unlesioned animals (Figs. 2F, G). No
hypointense signal was observed in animals receiving IBA
injection only, although their enlarged ventricles produced a
Figure 1 Isolation, MPIO labeling, and differentiation of neonatal rat MSCs. Flow cytometric analysis (A) showedmost cells coexpressed
CD54, collagen type 1, and integrin β1, and were negative for the hematopoietic stem cells markers CD45 and CD14. Different
concentrations of MPIO particles were tested for the maximum uptake of in culture (B). MPIO particles were seen in the cytoplasm by
fluorescence microscopy (C). Following incubation with MPIO particles, MSCs grew normally (C) and kept their adipogenic and
osteopogenic potential even after 10 passages (D–G). After 3 weeks in adipogenicmedium,MSCs differentiated into adipocytes containing
fat droplets, which are shown in red with Red O oil (RedO) staining (D). Dragon green (DG) MPIO-labeled cells (E) colocalized with
fat-containing cells (arrows). Similarly osteogenic medium induced differentiation into brown bone cells as visualizedwith Von Kossa (VK)
staining (F) which also colocalized with MPIO labeling (G, white arrows). Scale bars C=30 μm, D–G=100 μm.
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of accumulation of MPIO labeling were found close to
periventricular hyperintense regions, suggesting that labeled
cells gather close to more severely damaged areas (Fig. 2E).
The long distance between regions of hypointense signal
excludes the possibility of leaking of injection volume and
movement during the injection procedure. In addition these
regions were not seen within 2 days of injection but only
from 8 days posttransplantation.
Cell accumulations identified by MRI could be located
postmortem in sections by microscopy (Fig. 3A). No labeled
cells were observed in animals given CM. Many of the
DG-labeled cells remained in the injection site after grafting
(Figs. 3C, 5A), but cells also moved away from the injection
site. DG-labeled cells were found in the brains of 12 out of 14
animals that did not undergo MRI (P14 or adult). However, inmost cases only a few cells could be observed. Cells may have
been located in the large cystic cavities or necrotic areas and
mechanically lost during tissue processing, or injected into
the ventricles. Microscopy detected labeled cells lining the
wall of the lateral ventricle (Fig. 3B), and within the CC,
close to the lesion site ipsilateral to the transplant but also
near the lesion site in the contralateral hemisphere (Fig. 3C).
Labeled cells were not found in lateral parts of the CC or in
the cortical grey matter (Figs. 3C, 5B). Overall, they were
found ipsilateral to the transplant but away from the
injection site in 10 cases and in the contralateral white
matter in 6 cases. No signs of cell differentiation were
observed (data not shown) either at P14 or in adult rats as no
DG labeling was colocalized with immunoreactivity for a
mature neuron marker (NFNP), oligodendrocyte marker
(MBP), or astrocyte marker (GFAP).
Figure 2 In vivoMRI of MPIO labeling. MR images showed evidence of migration of MPIO-labeled cells, which exhibited a hypointense
iron contrast signal, both transcallosally (A–D) and posteriorly to the fornix and fimbria of hippocampus (E; Co, cortex; St, striatum;
Th, thalamus). Asterisks mark the site of migrated cells which were not observed 2 days posttransplantation (P8). Arrows mark the
original injection site. E also shows MPIO signals (hypointense) near hyperintense regions characteristic of lesioned tissue. F and G
show injection of labeled MSCs into unlesioned brain. No evidence of migration was found, although a hypointense region on the
surface of the brain may represent a blood clot (c). In lesioned brain with no transplant (H) no hypointense regions were observed,
although the enlarged ventricles (v) appeared hyperintense. Scale bars A–D, F–H=2.5 mm, E=2 mm.
258 A. Chen et al.Behavioral testing
Fig. 3 shows the success rate for reaching and retrieving food
rewards on4 successiveweeks. ANOVAanalysis revealed that all
groups improved with successive weeks, particularly over the
first 2 weeks. During the first week of testing, the IBA+MSCs
groupwas quicker to learn to reach for the food (7 out of 10 rats
made reaches) and made a significantly higher number of
successful reaches than IBA+CM animals (4 out of 7 made
reaches). By the second week more animals participated in the
task (9 out of 10 IBA+MSC rats and 4 from 7 IBA+CM) and were
more proficient; however, the IBA+MSCs group was twice as
successful. At the third and fourth week, nearly all rats
participated in the task (9 out of 10 IBA+MSC rats and 6 out
of 7 IBA+CM rats) and showed improved proficiency. ANOVA
analysis showed that the IBA+MSCs group was significantly
more proficient (Pb0.05) at the reaching task than control
group (Fig. 3).
Measurement of myelination and ventricle size
As shown previously (Chen et al., 2008) hypomyelination in the
CC was observed following IBA injection at P5. The localized
reduction of MBP immunoreactivity in the CC was also seen in
IBA+CManimals but itwas not obvious in IBA+MSC rats (Fig. 4).
In addition, the staining pattern of MBP immunoreactivity
observed was similar in both left and right CC in all animals.
ANOVA analysis of the optical density of myelin immunoreac-
tivity expressed as a ratio of the density in theCC to the density
in the AC showed that IBA+MSC animals had significantly
denser myelination in the CC compared with the control group
(Fig. 4).
Enlarged ventricles were found in brain sections from
adult animals receiving either CM or cell grafts (Fig. 4). Both
the total cross-sectional area of selected brain sections and
the average of the ventricular cross-sectional area as aproportion of the total brain cross-sectional area showed no
statistically significant difference between experimental
groups.
Cell proliferation in the forebrain
MSC transplantation produced increased myelination and
improved behavioral performance compared to controls, but
this was independent of a significant degree of transdiffer-
entiation of the MSCs into neural cells. Therefore a cell
proliferation assay (BrdU incorporation) investigated the
potential effects of grafted MSCs or CM only on cell
production in the host brain. BrdU+cells were mostly found
in the periventricular area, but also scattered through the
striatum, white matter, and cortex (Fig. 5). In the cortex,
BrdU+cells were found in all layers.
Significantly higher numbers of BrdU+cells were found in
the cortex and subcortex from animals with cell transplants
than from controls (Fig. 5). BrdU+cells in the right cortex
and subcortex ipsilateral to the site of MSC transplantation
were increased by 70 and 61% in comparison with IBA+CM. In
addition, they were increased by 59 and 53% in the left
cortex and subcortex in animals with MSCs compared to
controls. It also showed that there was no significant
difference between left and right for either cortical or
subcortical areas, with or without MSC transplants.Discussion
We have demonstrated that intracerebral transplants of
MPIO-labeled MSCs reduced hypomyelination of the CC
carrying axons to and from the sensorimotor cortex and
rescued development of skilled reaching and retrieval
function following IBA injection in rat pups, compared to
controls receiving CM only (this study) and probably to
Figure 3 Microscopic observation of MPIO/DG labeling. Following transplantation, accumulations of MPIO particles could be
identified in vivo by MRI as hypointense (dark) regions, confirmed by fluorescence microscopy in postmortem brain sections at P56 to
identify accumulations of DG labeling (A). Evidence of migration could be seen in both the short term and the long term after
transplantation. B shows DG-labeled cells at P14 (8 days posttransplantation) located along the wall of the ventricles, although they
could occasionally be seen in myelinated (MBP) areas. C shows iron-labeled cells (brown stain) in Nissl-stained sections 7 weeks after
transplantation (P56). The original injection site is clearly seen (asterisk) at the bottom of the injection track (arrow) in the wall of the
ventricle. Labeled but undifferentiated cells are seen in the corpus callosum (cc) ipsilateral (1) and contralateral (3) to the injection
site, as well as near to the injection site (2). Scale bars: A=2 mm, B=200 μm, C=500 μm.
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2008), although caution is required in comparing results from
experiments carried out at different times). Considering the
short time interval between lesioning and transplantation,
the effects of the transplant may be protective, or
reparative, or both. Indirect observation by MRI suggested
that the MSCs have the capability of surviving for at least a
few days and even migrate to lesioned areas. MSC transplants
have been previously demonstrated to have efficacy for
treating a variety of nervous system disorders. Adult rats
treated with an intracerebral injection of human MSCs
1 week after middle cerebral artery occlusion showed
restored skilled reaching and retrieval function to approxi-
mately 80% of baseline performance (Andrews et al., 2008).
A recent study has transplanted human MSCs by intracardial
injection into a rat model of neonatal hypoxic–ischemic
brain injury and shown improvements in motor performance
(Lee et al., 2010). Our present study added to these findings
by directly injecting stem cells to the lesion site, using awell-characterized model for PVWMI and a behavioral test
specific for corticospinal function, and a method for tracking
transplanted cells in vivo.Use of MPIO-labeled MSCs
Identifying the location of transplanted cells, both in vivo
and postmortem, aids the understanding of both the fate of
the stem cells posttransplantation and their possible
mechanisms of therapeutic actions (Dunning et al., 2004,
2006). A drawback is the potential toxic effect of the label on
the stem cells and even the host tissue. We found that
labeled MSCs survived and retained their capacity to
differentiate in vitro, allowing us to transplant them in
vivo. Improvements seen in treated animals compared to
controls suggests that labeled cells are not overtly toxic
when transplanted but it remains to be tested whether
unlabeled cells could be more efficacious.
Figure 4 Behavioral testing of corticospinal function. A shows successive images of a rat successfully reaching through a slit to
retrieve a grain of puffed rice from a tray. A hole in the tray forced the rat to pick up the food, not drag it back with paw or tongue
(taken from (Chen et al., 2008)). A reaching success score for each test was calculated: success%=(number of successful reaches/total
number of reaches)×100, if the animal attempted 41–60 reaches within 45 min; or success%=(number of successes/40)×100, if animal
attempted less than 40 reaches in 45 min. B shows the progression in proficiency in reaching over time in weeks (W) after weaning.
IBA+MSC animals generally learned quickly and reached for the food pellets accurately. IBA+CM animals were not able to reach
initially but eventually learned to retrieve the food pellets although without achieving the same proficiency as animals with cell
transplants. ANOVA analysis shows that IBA+MSC animals are significantly more proficient than IBA+CM animals at all four time
points. Error bars show standard error of the mean (SEM). * Pb0.05.
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spin label remained at or near the site of injection but with a
clearmigration of labeled cells in thewhitematter fiber tracts
in IBA injured brain, from the site of deposition to the lesion,
also laterally, contrallaterally, and posteriorly along white
matter tracts, over a period of 7 weeks but mostly within the
first week posttransplantation. Accumulation of MSCs in the
white matter might have some connection with the neurolog-
ical improvement in treated animals, although the detailed
mechanism is not clear. Alternatively, the longitudinal
arrangement of axons and oligodendrocyte processes may
provide a substrate along which cells can migrate.
Examination of histological sections postmortem found
deposits of spin label in locations that correlated with
hypointense spots on the MR images. Sometimes this label
appeared localized to relatively undifferentiated cells,
sometimes not obviously within cells at all. This suggests
the presence of labeled MSCs along the migratory pathways
and at sites of accumulation, although they may not all
survive long term. It appeared that grafted MSCs preferen-
tially navigated toward lesioned areas. The migration was
not an artifact of leaking of the injected volume of cells, nor
an inherent affinity of the MSCs toward certain brain areas,
because in control animals without prior toxin injection
labeled cells did not exhibit migratory properties. Alterna-
tively, IBA injection may stimulate microglia and macro-
phages, which can take up MPIO label from dead
transplanted cells (Pawelczyk et al., 2009) and migrate
along white matter tracts, giving the erroneous impressionthat MSCs had migrated; however, this is hard to reconcile
with the observed beneficial effects of MSC transplantation,
as accumulation of microglia in white matter is usually
associated with decreased myelination (Heppner et al.,
2005; Lechpammer et al., 2008; Rinner et al., 1995).
MPIO-labeled MSC transplants improved neurological
function and myelinationIntracerebral injection of IBA into P5 rat pups causes relative
failure of myelination and loss of performance in the reaching
and retrieving test compared to controls (Chen et al., 2008).
Corticospinal neurons fail to make correct axonal projections
because of focal oligodendrocyte loss and axon destruction.
Subsequently, the impaired myelination of growing axons
disrupts the normal development of cortical and subcortical
circuitry crucial for accurate motor control. In the current
study, MSC recipients have shown significant improvement in
the reaching and retrieving task correlated with increased
myelination when compared to CM-treated controls. MSC
treatment following IBA injection did not result in a decrease
in ventricle size or apparent brain tissue repair in the lesion
site, and no obvious signs of MSC transdifferentiation were
found, further supporting recent evidence that MSCs show
little or no capacity to differentiate into neural cells when
transplanted into other brain regions or in other CNS diseases
(Zwart et al., 2008, 2009; Rooney et al., 2009). Therefore,
functional recovery in skilled forelimb movements as seen in
Figure 5 Myelination of the corpus callosum. Representative, myelin basic protein (MBP)-immunostained sections from the IBA+MSC
(A) and IBA+CM (B) rat forebrain at the level of bregma. The reduction of MBP immunostaining in the corpus callosum (CC) caused by IBA
injection was clearly seen in animals with conditioned medium, but not following MSC transplants. For each animal, the MBP staining
pattern was the same for both the left and right hemisphere and enlarged ventricles were found in all cases. (C) Optical density
measurements (Chen et al., 2008) showed that the relative intensity of MBP immunoreactivity in the CC compared to the anterior
commissure (AC) was significantly increased in IBA+MSC animals compared to IBA+CM controls (* Pb0.05). Measurement of the total
cross-sectional area of the 6 selected forebrain sections each 1000 μmapart from the area of interest of each animal demonstrated that
MSC infusion did not lead to significant changes in brain volume, comparedwith conditionedmedium controls (C). There is no significant
difference in the average of the percentage of ventricular cross-sectional area/total forebrain cross-sectional area between the two
groups. Error bars represent standard error of the mean. Scale bar=2 mm.
261Transplantation of magnetically labeled MSCs in a model of perinatal brain injuryour experiment is not proven to have come from the functional
integration of the transplanted cells into the lesioned brain,
but may reflect other influences that MSC transplants could
bring, which could be protective or reparative.
In their original niche in bone marrow, MSCs provide not
only the structural framework for HSCs, but also various
growth factors and components of the extracellular matrix,
exerting both positive and negative regulatory effects on the
proliferation and differentiation of HSC (Verfaillie, 1993;
Eipers et al., 2000). When MSCs are grafted into various
tissues, they adapt their expression profile to match the host
tissue (Mangi et al., 2003). Thus, when exposed to the injured
CNS, MSCs secrete molecules important for axonal growth and
neuronal survival (Chopp and Li, 2002; Li et al., 2002; Chen et
al., 2003; Zhang et al., 2006). Furthermore, although MSCs
were only injected into the right hemisphere, we observed
labeled cells in bothhemispheres posttransplantation, thereby
allowing for possible widespread secretion of growth factors.
The neuroprotective and growth-promoting properties of
trophic factors secreted by MSCs may play an important role
in their effect on functional improvement.
MSCs have been reported to develop an almost exclusively
myelinating phenotype and form functional myelin when
grafted into a demyelinated spinal cord lesion (Akiyama et
al., 2002). However, MSCs can also instruct oligodendrogenic
fate decision in adult neural stem cells (NSCs) in culture,
mediated by unidentified soluble factors (Rivera et al., 2006).
MSCs have a second role in bone marrow as stromal cells:producing different signals affecting the biology of other adult
stem/progenitor cells. MSCs and NSCsmight similarly interact,
even under normal circumstances, because there is a dense
capillary network in the brain and MSCs are present in the
circulation. Provision of extra MSCs may enhance these
effects. MSCs and NSCs may have to interact through cell
contact, as conditioned medium on its own had less effect.IncreasecellproliferationinducedbyMSCtransplantation
Compared with controls, significantly more BrdU-labeled
cells, a marker for cell proliferation, were found in both
hemispheres of forebrains with MSC grafts, including the
cortical and subventricular areas, which may contribute to
the observed functional improvement. Although BrdU may
also be taken up by injured cells that can initiate DNA
synthesis prior to apoptosis (Kuan et al., 2004) the increased
presence of damaged cells in animals receiving transplants is
not expected. We propose that the grafted MSCs may
promote the generation of new cells from local progenitors
and/or migration of new cells into the lesion area, and these
newborn cells may compensate the lost function of insult-
damaged cells. As neurogenesis in the forebrain is almost
complete prenatally in rat (Bayer and Altman, 1990), the
newborn cells must be predominantly astrocytes and
oligodendrocytes, which continue to be generated in the
first month postnatally (Bayer and Altman, 1990).
262 A. Chen et al.After injury in the adult CNS, glial scar formation presents
a barrier to regeneration (Liuzzi and Lasek, 1987; Rudge and
Silver, 1990; Fitch and Silver, 1997, 2008); however, glial
scars are not formed initially in PVWMI (McQuillen and
Ferriero, 2004). Reactive astrocytes that appear in any case
after IBA injection (Chen et al., 2008) may support and guide
in axon growth (Ajtai and Kalman, 2001) as they do in the
normal developing CNS (Rakic, 1978; Vaccarino et al., 2007).
Thus, MSCs may exert neuroprotective effects and support
axon growth by promoting the proliferation and migration of
astrocytes. The increased myelination observed following
MSC transplantation may have resulted from increased
proliferation of oligodendrocytes, or the MSCs may have
also protected preoligodendrocytes local to the lesion site.
Since oligodendrogenesis and astrocytogenesis begin post-
natally in the rodent, further comparison between the MSCs
induced proliferation and the process in the normally
developing brain is needed. There are other possible
mechanisms responsible for the promising outcomes after
transplantation, such as trophic factor delivery and immu-
nomodulation. The failure of MSCs to undergo division or
prolonged survival in large numbers need not necessarily be
seen as a drawback as it makes it less likely that unwanted
tumor formation will occur.
Conclusions
Our preliminary study provides promising results regarding
the possibilities of autologous MSC therapy for PVWMI. The
cell transplants cause no harmful side effects, instead
improvements in behavioral function and a reduction in
hypomyelination compared to controls receiving conditioned
medium were observed. How this was achieved is still not
clear, although the presence of transplanted cells seems
important. However, in future experiments, comparisons
between conditioned medium and saline injections might
reveal the contribution of secreted cytokines to the effect. It
seems more likely that the transplanted cells boost prolif-
eration and survival of host neural cells rather than
transdifferentiating into neural cell types themselves. MPIO
labeling provides a safe and feasible way of tracking
transplanted cells in the neonatal brain by in vivo MRI.
Materials and methods
Animals
Wistar rats were purchased from Charles River Laboratories
(East Lothian, UK) and housed in the Newcastle Comparative
Biology Centre. All procedures were performed with the
approval of the Local Ethics Review Committee and UK
Government Home Office. Fifty-six rats were used; 14 for the
isolation of MSCs, 20 for the study of transplantation effects,
10 for a cell proliferation assay, and 12 for an MRI study.
Cell culture
MSCs were isolated and expanded according to a protocol
modified from previous reports (Woodbury et al., 2000,
2002). Neonatal rats were humanely killed and their tibiasand femurs dissected. P7 (day of birth taken as P0) was
chosen to match the developmental stage of premature
human babies, in terms of neurodevelopment (Clowry, 2007)
and long bone development (Morini et al., 2004; Burkus et
al., 1993). Marrow was extruded from the medullary cavities
of cut bones with 5 ml of phosphate-buffered saline (PBS)
with 5% fetal calf serum (FCS) via a 25-G needle. Following
centrifugation (1000 rpm, 10 min), the cells were resus-
pended with 80% MesenCult basal medium+20% mesenchy-
mal stem cell stimulatory supplements (Stem Cell
Technologies, France). About 1×108 bone marrow cells
were plated in a 75-cm2 tissue culture flask in 10 ml medium,
and incubated at 37 °C in 5% CO2. After 24 h, nonadherent
cells were removed by replacing the medium, which was
further replaced every 2–3 days as the cells were grown to
confluency. Cells were lifted by incubation with 0.05%
trypsin–0.53 mM ethylenediaminetetraacetic acid for 3 min
at 37 °C. For each passage, the cells were plated at 8000
cells/cm2 and grown to confluency. Cells were stored in
liquid nitrogen in freezing medium with 90% FCS and 10%
dimethyl sulfoxide.
Immunophenotype of rodent MSCs
A characterization kit (Milipore, Hampshire, UK) was used for
phenotypic assay. Some cells were fixed with 4% paraformal-
dehyde (PFA, Sigma-Aldrich, Poole, UK) in PBS and incubated
with rabbit polyclonal antibodies against fibronectin, collagen
type 1, or integrin beta 1 diluted 1:500 in a permeabilizing
blocking solution (5% normal serum, 0.1% Triton X-100 in PBS,
PBST). Some cells remained unfixed and were incubated with
one of three mouse monoclonal antibodies directed against
CD54, CD45, or CD14 diluted 1:100 in nonpermeable blocking
solution (5% normal serum in PBS). Following incubation
overnight at 4 °C and washing, cells were incubated with
appropriate fluorescein isothiocyanate (FITC)-conjugated sec-
ondary antibody (diluted at 1:100 in blocking solution) for 2 h
and then cell nuclei were counterstained with 4′,6-diamidino-
2-phenylindole (DAPI)/1X PBS solution. Rabbit and mouse
immunoglobulins were used to assess background staining.
The same primary and FITC-conjugated secondary anti-
bodies were used for flow cytometric analysis. Cells were
incubated with primary antibodies for 2 h, and then with
secondary antibodies for 1 h at 4 °C. Flow cytometry was
performed on a FACSCalibur flow cytometer (Becton Dickinson,
Oxfordshire, UK), and data were analyzed with Cellquest
software.
Cell labeling with MPIO and effects on differentiation
potential
MPIO particles (Bangs Laboratories, IN, USA) of diameter
1.63 μm and internally labeled with dragon green (DG) were
used to label stem cells. Particle concentration was optimized
for maximum uptake by testing 1, 5, 10, 20, and 50 μl/ml in
medium. MSCs were cultured to 60–70% confluency and
incubated with MPIO particles for 20 h. Labeling efficiency
was measured by flow cytometry. The optimal concentration
was used in later experiments (Fig. 1B).
For osteogenic differentiation, MPIO-labeled or unlabeled
MSCs were maintained in osteogenic induction media
263Transplantation of magnetically labeled MSCs in a model of perinatal brain injury(mesenchymal stem cell osteogenic stimulatory kit, Stem
Cell Technologies). MSCs were plated in osteogenic media
without β-glycerophosphate and refed every 2–3 days with
fresh induction media without β-glycerophosphate. Media
with β-glycerophosphate were used only after cell multi-
layering had been observed. After 3 weeks mineralization in
cultures, a marker for osteogenic differentiation was
detected with von Kossa's staining. A negative control was
provided by treating cells with normal medium.
Adipogenesis induction medium (Millipore) was applied
when MSC cultures were 100% confluent and then culture
media were replaced with fresh adipogenesis induction or
maintenance medium every other day for 21 days. Red O oil
staining was used to detect lipid droplets, a marker for
adipogenic differentiation.
Animal surgery
After IBA injection at P5, rats were randomly divided into
two groups: (1) IBA+conditioned medium (CM), with CM
infusion at P6; (2) IBA+MSCs, with MSC transplantation at P6.
The PVWMI model was created by bilateral intracerebral
injection of IBA as described previously (Chen et al., 2008).
The rats were anesthetized by injection of 0.3 μg/kg body
weight fentanyl citrate and 10 μg/kg fluanisine subcutaneous-
ly (Hypnorm, VetaPharma Limited, Leeds, UK) (Clowry and
Flecknell, 2000). At P6 animals were reanesthetized as above.
Two microliters of MPIO-labeled MSCs, second or third
passage, at a concentration of 5×105/μl in medium was
injected by a Hamilton syringe into the right hemisphere near
the IBA injection site, at the location of 1.5 mm posterior and
2.0 mm lateral to bregma and 2.0 mm deep to the skull
surface. Animals injected with 2 μl medium conditioned by
24 h culturing with MSCs served as a control group. This
procedure controlled for the injection of fluid into the
forebrain and any molecules secreted into the suspension
medium by MSCs.
Reaching test
A reaching and retrieval test was performed as previously
described (Chen et al., 2008). The animals were tested once
a week over 4 weeks (W1 to W4), starting after weaning at
P28.
Histology
Animals were killed at P14, or after the final trial of the
reaching test, by transcardial perfusion with 0.9% saline
followed by buffered fixative 1 ml/g body weight, consisting
of 4% PFA in PBS, following induction of terminal anesthesia
with injection of sodium pentobarbitone. Brains were
removed, postfixed for 2 h, and left in 30% sucrose/PBS at
4 °C overnight. Transverse sections (50 μm of thickness) of
forebrain were cut on a freezingmicrotome and placed in PBS.
For adult brains (7 IBA+CM, 10 IBA+MSCs), one set of
sections was mounted on gelatine-coated slides and Nissl-
stained with cresyl violet. One set of free-floating sections
was incubated with primary antibodies for myelin basic
protein (MBP, SMI-94, Sigma-Aldrich, 1:1000 in 0.3% PBST)
and 3% blocking serum (Vector Laboratories, Peterborough,UK) overnight at 4 °C. Following washing in PBS, sections
were incubated with biotinylated secondary antibodies
(Vector Labs, 1:200 in PBST) for 2 h at room temperature,
washed in PBS, and incubated for a further hour with
streptavidin–horseradish peroxidase (1:200 in PBST; Vector
Labs). Sections were reacted with 0.05% diaminobenzidine/
0.003% hydrogen peroxide (Sigma-Aldrich) in PBS, washed,
and mounted on slides. All sections were dehydrated,
cleared, and mounted in Entellan (Merck, Loughborough,
UK). The extent of the white matter lesion was determined
in adult animals by measuring the optical density of anti-MBP
immunostaining, as previously described (Chen et al., 2008).
All measurements were made blind.
The identity of DG-labeled cells was investigated with
double-immunofluorescent staining for sections from 3 P14
and 3 adult brains from IBA+MSCs. Three sets of free-floating
sections were stained for anti-MBP, anti-nonphosphorylated
neurofilament (NPNF: 1:1000, Sigma-Aldrich), or glial fibril-
lary acidic protein (GFAP: 1:500, Sigma-Aldrich) in PBST.
Following overnight incubation with primary antibodies,
sections were incubated with anti-mouse Cy3-conjugated
secondary antibody (Vector Labs, 1:200 in PBST). The
colocalization of Cy3-labeled antibody and DG-labeled cells
was checked using a Leica SP2 confocal scanning microscope.
In vivo MRI
MRI was employed to locate MSCs postgrafting via the effect
of the MPIO particles on imaging contrast. Twelve rats were
divided into 3 equal groups for MRI scanning: (1) unlesioned
animals+MSCs at P6 (2) IBA+CM; and (3) IBA+MSCs. MRI
experiments were performed on P7–8, P14–15, P27–29, and
P54–56.
Each rat was anesthetized with 4–5% isoflurane (IsoFIo,
Abbott Laboratories. Ltd, Kent, England) in 95% O2 and
maintained with 1.75–2.5% isoflurane at a flow rate of
0.2–0.3 L/min O2 and placed in an animal holder with its
head inside the imaging coil. Eyes were protected with eye
lubricating ointment (Almus, Surrey, UK). Respiratory rate
was monitored throughout and body temperature main-
tained by circulating warm air at 37 °C. MRI was performed
using a 7.0-Tesla (T)/MRI system (Varian Inc., Palo Alto, USA)
equipped with a 39-mm-bore volume imaging coil (Rapid
Biomedical GmbH, Würzburg, Germany) and VnmrJ soft-
ware. All MRI used a three-dimensional (3D) GE sequence. As
MR contrast varied with brain maturation the precise imaging
parameters used were TR/TE 20/3.5 ms for the first three
ages investigated and TR/TE 20/7.0 ms for the fourth age. All
scans were acquired with 8° flip angle, field of view
18×26×15 mm3, matrix size 128×128×32, 30 averages,
and with magnetization transfer (225° flip angle, 1.5 ms
duration, 1500 Hz offset). After the final scan, animals were
perfused with fixative and coronal or axial brain sections cut.
Localization of MPIO-labeled cells seen in MRI images was
confirmed by microscopy.
Cell proliferation assay
After injection of IBA at P5 and MPIO-labeledMSCs (n=6) or CM
(n=4) at P6, pupswere injectedwith 5-bromo-2′-deoxyuridine
(BrdU, Sigma-Aldrich) solution 50 mg/kg ip once per day for
Figure 6 Quantification of cell proliferation followingMSC transplantation. A shows a large concentration of BrdU-immunoreactive cell
nuclei near to the lateral ventricle (V), corpus callosum (CC), and striatum (Str). B shows BrdU-labeled cells in outer layers (I and III) of the
cortex. C shows a representative section for BrdU+cell counting. Cortex refers to the area outside the black dashed line; subcortex refers
to the area inside the black dash. D is a comparison of the numbers of BrdU+cells in the different areas showing that statistically higher
numbers of BrdU+cells were found in IBA+MSC animals than in IBA+CM animals, for the left and right cortex and subcortex. * refers to
Pb0.05. Scale bar=200 μm in A, 100 μm in B.
264 A. Chen et al.3 days (P6, P7, and P8). Animals were perfusedwith fixative at
P13 and the brains sectioned with a cryostat (12 μm thick) and
mounted on gelatine-coated slides. BrdU incorporation by
dividing cells was detected by immunohistochemistry. After
incubation in 2 N hydrochloric acid (Sigma-Aldrich) at 37 °C for
50 min, sections were washed in PBS (pH 8.4) for 10 min.
Following a 1-h incubation with 0.3% PBST/5% normal serum,
sections were incubated with anti-BrdU antibody (mouse
monoclonal, Sigma-Aldrich) overnight at 4 °C, diluted at
1:1000 in PBST. Anti-mouse IgG (whole molecule) F(ab′)2
fragment-Cy3, produced in sheep (Sigma-Aldrich, 1:100), was
used for visualization.
BrdU+cells were counted for each animal from two
sections from the level of bregma and from 1 mm anterior
to bregma. Each section was divided into two regions,
cortical and subcortical (Fig. 6). 20 fields under high
magnification from left and right cortex, and from left and
right subcortex were randomly chosen and BrdU+cells were
counted blind.
Statistical analysis
SPSS software was used to perform ANOVA to test the effects
of the infusion of MSCs or conditioned medium on neurolog-
ical function at 4 consecutive weeks, differences inventricular size, myelin density, and cell proliferation. Post
hoc multiple comparisons were employed where required.Acknowledgments
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